feed,title,long_url,short_url
Benzinga,AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer's disease met its primary endpoint,https://www.benzinga.com/pressreleases/20/12/g18809639/ab-science-announces-that-phase-2b3-study-evaluating-oral-in-alzheimers-disease-met-its-primary-en,https://j.mp/2WjrZON
